PeptidePedia The community reference

Contributions of SurpassSunniva

User contributions·22 logged edits·page 1 of 1

Contributions by SurpassSunniva, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,622 edits includes activity predating the current log.

  1. 14:43, 15 Jul 2026 (diff | hist) Vial 26,012 ±0 correct the transit-time figure — the source gives a median, not a maximum
  2. 22:58, 6 Mar 2026 (diff | hist) Sterile water for injection 4,738 ±0 m add the beyond-use interval with the storage condition it assumes
  3. 19:57, 7 Feb 2026 (diff | hist) Haemoglobin A1c 4,243 ±0 m attribute the population interval to the cohort it was derived from
  4. 20:13, 5 Feb 2026 (diff | hist) Number needed to treat 4,718 ±0 m flag the pooled analysis as post hoc
  5. 04:45, 28 Jan 2026 (diff | hist) Amylin receptor agonist 5,245 ±0 m typo
  6. 09:50, 26 Jan 2026 (diff | hist) Talk:SURPASS trial programme 400 +178 /* Cross-trial comparison of SURMOUNT and STEP */ new section
  7. 16:29, 19 Nov 2025 (diff | hist) SURMOUNT trial programme 5,021 ±0 add the run-in period, which changes how the baseline reads
  8. 09:26, 15 Oct 2025 (diff | hist) Talk:Trial data comparison 1,307 +96 /* Head-to-head filter: is the flag applied consistently? */ reply
  9. 12:44, 13 Oct 2025 (diff | hist) Talk:Trial data comparison 674 +268 /* Head-to-head filter: is the flag applied consistently? */ new section
  10. 03:47, 28 Aug 2025 (diff | hist) STEP trial programme 5,534 +283 name the funder in the sentence, per PP:MOS
  11. 08:00, 4 Aug 2025 (diff | hist) STEP trial programme 5,251 ±0 typo
  12. 07:37, 14 May 2025 (diff | hist) Enteroendocrine L cell 4,648 ±0 add short description
  13. 14:56, 7 May 2025 (diff | hist) Janoshik Analytical 4,999 +30 state the method the reporting service uses, since it is not the only one available
  14. 00:52, 24 Mar 2025 (diff | hist) Liraglutide 4,532 ±0 expand §Clinical evidence
  15. 23:35, 21 Mar 2025 (diff | hist) FLOW trial 3,456 +287 m name the funder in the sentence, per PP:MOS
  16. 12:33, 10 Mar 2025 (diff | hist) SURMOUNT trial programme 3,559 ±0 m add the PMID
  17. 03:36, 28 Jan 2025 (diff | hist) Janoshik Analytical 4,126 ±0 state the date range the submitted set covers
  18. 18:27, 3 Jan 2025 (diff | hist) Number needed to treat 3,207 ±0 add the run-in period, which changes how the baseline reads
  19. 07:50, 3 Jan 2025 (diff | hist) FLOW trial 2,601 ±0 close an unbalanced quotation mark
  20. 12:30, 25 Dec 2024 (diff | hist) Reference standard 3,767 ±0 rm the claim that the method is stability-indicating without a forced-degradation study
  21. 11:36, 14 Dec 2024 (diff | hist) SURMOUNT trial programme 3,137 +435 m add the missing-data handling method
  22. 03:21, 9 Nov 2024 (diff | hist) High-performance liquid chromatography 4,203 +37 expand §Hyphenated and preparative variants